All lobbying filings

LMH STRATEGIC SOLUTIONS

Lobbying for IONIS PHARMACEUTICALS, INC. · Biotechnology company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $20,000.00 income · posted Apr 18, 2025

Official filing document

Bills named in this filing 6

HR 5547
Maintaining Investments in New Innovation Act
S 476
Maintaining Investments in New Innovation Act
HR 7384
Creating Hope Reauthorization Act of 2024
HR 946
ORPHAN Cures Act
HR 1509
Accelerating Kids’ Access to Care Act of 2025
S 752
Accelerating Kids’ Access to Care Act

Lobbying activity 1

Health Issues

Issues related to the implementation of H.R.5547/S.476 - Maintaining Investments in New Innovation Act and H.R.7384 - Creating Hope Reauthorization Act of 2024. Pediatric Review Reauthorization. H.R.946 - ORPHAN Cures Act. H.R.1509/S.752 - Accelerating Kids Access to Care Act of 2025.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.